AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $282,000 | +89.3% | 18,628 | -6.1% | 0.00% | – |
| Q2 2022 | $149,000 | -19.9% | 19,845 | -2.9% | 0.00% | – |
| Q1 2022 | $186,000 | +42.0% | 20,443 | +9.3% | 0.00% | – |
| Q4 2021 | $131,000 | -40.5% | 18,700 | -3.3% | 0.00% | -100.0% |
| Q3 2021 | $220,000 | -13.4% | 19,336 | +22.0% | 0.00% | 0.0% |
| Q2 2021 | $254,000 | -11.5% | 15,854 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $287,000 | +26.4% | 16,033 | -4.7% | 0.00% | 0.0% |
| Q4 2020 | $227,000 | -13.0% | 16,826 | -24.2% | 0.00% | 0.0% |
| Q3 2020 | $261,000 | -23.2% | 22,206 | -3.6% | 0.00% | -50.0% |
| Q2 2020 | $340,000 | +10.0% | 23,024 | +0.5% | 0.00% | 0.0% |
| Q1 2020 | $309,000 | -27.3% | 22,899 | +30.2% | 0.00% | 0.0% |
| Q4 2019 | $425,000 | +106.3% | 17,585 | +63.9% | 0.00% | +100.0% |
| Q3 2019 | $206,000 | -10.8% | 10,726 | +120.9% | 0.00% | 0.0% |
| Q1 2019 | $231,000 | +4.5% | 4,856 | -20.6% | 0.00% | 0.0% |
| Q4 2018 | $221,000 | -17.8% | 6,115 | +39.8% | 0.00% | 0.0% |
| Q3 2018 | $269,000 | -2.5% | 4,375 | +7.0% | 0.00% | -50.0% |
| Q2 2018 | $276,000 | – | 4,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|